Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory breast carcinoma. Effective multimodal approach.

G V Burton1, E B Cox, G S Leight

  • 1Department of Medicine, Duke University Medical Center, Durham, NC.

Archives of Surgery (Chicago, Ill. : 1960)
|November 1, 1987
PubMed
Summary

This study evaluated a chemotherapy regimen for inflammatory breast carcinoma. The treatment showed promising disease-free survival rates, suggesting a favorable comparison to other therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on desmoid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Cascade Stomach.

Canadian Medical Association journal·2010
Same author

Monitoring antitumour immune response during immunotherapy of cancer: why and how?

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Same author

Thoracic metastases from breast cancer: a single-institution's experience.

European journal of gynaecological oncology·2005
Same author

Supraclavicular nodal relapse of breast cancer: prevalence, palliation, and prognosis.

European journal of gynaecological oncology·2003
Same author

"Routine" weekly blood counts during breast irradiation for early stage cancer: are they really necessary?

The breast journal·2002

Area of Science:

  • Oncology
  • Medical treatment protocols
  • Breast cancer research

Background:

  • Inflammatory breast carcinoma (IBC) is an aggressive form of breast cancer.
  • Optimal treatment strategies for IBC require ongoing investigation.
  • Neoadjuvant and adjuvant therapies are crucial in managing IBC.

Purpose of the Study:

  • To assess the efficacy of a specific preoperative and postoperative chemotherapy regimen for IBC.
  • To evaluate disease-free survival (DFS) and overall survival (OS) in patients receiving this treatment.
  • To compare the outcomes of this regimen with established chemotherapy protocols for IBC.

Main Methods:

  • Twenty-two patients with IBC received six weeks of preoperative chemotherapy (cyclophosphamide, doxorubicin hydrochloride, fluorouracil, vincristine sulfate).

Related Experiment Videos

  • Postoperative therapy included 22 weeks of biweekly administration of the same drugs.
  • Chemotherapy was followed by regional radiotherapeutic consolidation.

    • Main Results:

    • Nineteen out of 22 patients completed the full treatment protocol.
    • Twelve patients remained disease-free at a median follow-up of 15 months (range: 4-32 months).
    • Median DFS for all 22 patients was at least 13 months (range: 0-32 months), and median OS was at least 18 months (range: 1-33 months).

    Conclusions:

    • The evaluated chemotherapy regimen, combined with radiotherapy, demonstrated favorable outcomes in IBC patients.
    • This treatment protocol shows promising disease-free and overall survival rates.
    • The regimen appears to compare favorably against prolonged adjuvant and maintenance chemotherapy strategies for IBC.